A Study of Self-reported Outcomes in Patients with Multiple Sclerosis (MS)


About this study

The purpose of this study is to determine clinical outcome following treatment for multiple sclerosis (MS) relapse, in patients who were seen at Mayo Clinic.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Multiple Sclerosis patients that have received treatment for a multiple sclerosis relapse at Mayo Clinic in Rochester, Minnesota from 1990 to 2017.
  • Age 18 and greater
  • Willingness to complete survey assessment

Exclusion Criteria:

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

W. Oliver Tobin, M.B., B.Ch., B.A.O., Ph.D.

Closed for enrollment

Contact information:

William Tobin M.B., B.Ch., B.A.O., Ph.D.



More information


Publications are currently not available

Mayo Clinic Footer